With the Aviva share price over £4, should investors consider buying?

Despite rising above £4 per share, FTSE 100-star Aviva is undervalued to its peers, has great growth prospects, and I think its yield looks set to soar.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Bearded man writing on notepad in front of computer

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Aviva (LSE: AV) share price is still trading over £4, having been lifted by takeover speculation.

Having worked in global financial markets for many years, I have found such rumours usually groundless. If any genuine takeover move had been made, Aviva would have been legally obliged to tell shareholders, which has not happened.

This aside, I already have holdings in the company, for three very good reasons, in my view.

Streamlined and refocused

The first is that since she took over as CEO in 2020, Amanda Blanc has brilliantly streamlined and refocused the company. So brilliantly, in fact, that her efforts have been praised by the notoriously difficult-to-please hedge fund manager Cevian.

After Aviva’s 2022 results, Cevian – a minority shareholder — said Blanc had done an “excellent job in restructuring the company”.

Indeed, from 2020 she oversaw the sale of eight non-core businesses, raising around £7.5bn. She also refocused the business on increasing wealth fund flows from the UK, Ireland, and Canada.

2022 operating profit rose 35%, despite difficult financial market conditions. And in its Q1 2023 update, it said it is also on track to beat its own funds generation target of £1.5bn a year by the end of 2024.

A risk remains, of course, that high inflation and interest rates reduce client business.

Undervalued to peers

The second reason is that Aviva still looks undervalued compared to its peers.

Despite the recent rise in its shares, it currently trades at a price-to-book ratio (P/B) of just 1.2. Phoenix Group Holdings trades at 1.4, Prudential at 1.8, Legal & General at 2.6, and Admiral at 7.7. The peer group average is 3.4.

This difference does not necessarily mean that Aviva’s P/B will completely converge to those of its peers. However, it does suggest to me that there is a fundamental technical reason for its shares to rise over time.

Huge passive income potential

The third reason is its huge passive income potential. In 2022, it paid an interim dividend of 10.3p per share, with a total payout of 31p. Based on the current share price of £4.09, this gives a yield of 7.6%.

However, the interim dividend this year increased by 8% (to 11.1p). If this was applied to the total payout, the dividend would be 33.48p, giving a yield of 8.2%.

Analysts’ forecasts are for similar rises to occur in 2024 and 2025, giving respective yields of 9.3% and 9.8%. These would put Aviva back into the elite group of companies that provide a 9%+ return.

Even at the current 7.6% though, a £10,000 investment would make an additional £760 over a year.

In 10 years, if the rate stayed the same, another £7,600 would be added to the initial £10,000. This is over and above share price gains or losses and tax obligations incurred, of course.

I already hold shares in the company, with an average price of £3.80. As a long-term investor now, 30p or so more is not a big deal on a £4 or so stock. However, the recent rise was driven by dubious rumours, in my view, and is therefore likely just a blip.

Consequently, if I were looking to establish a new holding, I would wait until the effect of the rumours on the shares fully wore off before thinking about buying.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Simon Watkins has positions in Aviva Plc, Legal & General Group Plc, and Phoenix Group Plc. The Motley Fool UK has recommended Admiral Group Plc and Prudential Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Closeup of "interest rates" text in a newspaper
Investing Articles

Interest rates fall again! Here are 3 FTSE dividend growth shares to consider buying

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for passive…

Read more »

Investing Articles

Up 10% today, I think this FTSE 250 growth share could continue to surge!

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be getting started.

Read more »

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »

Investing Articles

Is this my chance to buy Alphabet shares?

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy…

Read more »

Senior woman potting plant in garden at home
Investing Articles

£10k in savings? Here’s how an investor could aim for a monthly second income of £1,200

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio…

Read more »

Investing Articles

2 cheap shares to consider buying in a £20k ISA for income of £1,000 a year

Harvey Jones loves buying cheap shares and says these two FTSE 100 stocks look tempting today, especially as they offer…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Is it worth me buying Lloyds shares for 61p after a 49% rise?

Lloyds shares have risen significantly from their one-year traded low seen last February, which could mean no value is left…

Read more »

Investing Articles

I think this FTSE 100 fashion stock could skyrocket in 2025

JD Sports has had a disastrous few months of losses but 2025 looks primed to be the year for this…

Read more »